Caplacizumab use in immune-mediated thrombotic thrombocytopenic purpura: an international multicentre retrospective Cohort study (The Capla 1000+ project)Paul Coppo, Marie Scully, Paul Brinkkötter et al.|EClinicalMedicine|2025Cited by 41
Congenital and acquired ADAMTS13 deficiency: Two mechanisms, one patientBarbara Ferrari, Flora Peyvandi, Andrea Cairo et al.|Journal of Clinical Apheresis|2014Cited by 7